PMC Articles for MedGen (Select 1003613) - PMC

Result Filters

Links from MedGen

Items: 1 to 20 of 87

<< First< Prev

Page of 5

Select item 37399841.

Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients()

David R. Nelson, Stefan Zeuzem, Pietro Andreone, Peter Ferenci, Robert Herring, Donald M. Jensen, Patrick Marcellin, Paul J. Pockros, Maribel Rodríguez-Torres, Lorenzo Rossaro, Vinod K. Rustgi, Thomas Sepe, Mark Sulkowski, Isaac R. Thomason, Eric M. Yoshida, Anna Chan, George Hill

Ann Hepatol. Author manuscript; available in PMC 2013 Aug 10.

Published in final edited form as: Ann Hepatol. 2012 Jan-Feb; 11(1): 15–31.

PMCID:: PMC3739984

Abstract Article PDF–939K

Select item 33046502.

Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis

Kyung Hoon Kim, Byoung Kuk Jang, Woo Jin Chung, Jae Seok Hwang, Young Oh Kweon, Won Young Tak, Heon Ju Lee, Chang Hyeong Lee, Jeong Ill Suh

Korean J Hepatol. 2011 Sep; 17(3): 220–225. Published online 2011 Sep 30. doi: 10.3350/kjhep.2011.17.3.220

PMCID:: PMC3304650

Abstract Article PDF–443K

Select item 33600513.

Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3

Åsa Alsiö, Karolina Rembeck, Galia Askarieh, Peer Brehm Christensen, Martti Färkkilä, Nina Langeland, Mads Rauning Buhl, Court Pedersen, Kristine Mørch, Bart L. Haagmans, Salmir Nasic, Johan Westin, Kristoffer Hellstrand, Gunnar Norkrans, Martin Lagging

PLoS One. 2012; 7(5): e37521. Published online 2012 May 24. doi: 10.1371/journal.pone.0037521

PMCID:: PMC3360051

Abstract Article PDF–333K

Select item 33803244.

Impact of ribavirin dose on retreatment of chronic hepatitis C patients

Christiane Stern, Michelle Martinot-Peignoux, Marie Pierre Ripault, Nathalie Boyer, Corinne Castelnau, Dominique Valla, Patrick Marcellin

World J Gastroenterol. 2012 Jun 21; 18(23): 2966–2972. Published online 2012 Jun 21. doi: 10.3748/wjg.v18.i23.2966

PMCID:: PMC3380324

Abstract Article PDF–785K

Select item 35403725.

Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C

Seok Hoo Jeong, Young Kul Jung, Jae Won Yang, Sang Jin Park, Jong Woo Kim, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim

Clin Mol Hepatol. 2012 Dec; 18(4): 360–367. Published online 2012 Dec 21. doi: 10.3350/cmh.2012.18.4.360

PMCID:: PMC3540372

Abstract Article PDF–645K

Select item 35505986.

Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis

C. Cooper, R. Lester, K. Thorlund, E. Druyts, A.C. El Khoury, S. Yaya, E.J. Mills

QJM. 2013 Feb; 106(2): 153–163. Published online 2012 Nov 16. doi: 10.1093/qjmed/hcs214

PMCID:: PMC3550598

Abstract Article PDF–187K

Select item 36442807.

Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population

Young-Joo Jin, Jin-Woo Lee, Jung il Lee, Sang Hoon Park, Choong Kee Park, Young Seok Kim, Sook-Hyang Jeong, Yun Soo Kim, Ju Hyun Kim, Seong Gyu Hwang, Kyu Sung Rim, Hyung Joon Yim, Jae Youn Cheong, Sung Won Cho, June Sung Lee, Young Min Park, Jeong Won Jang, Chun Kyon Lee, Joo Hyun Sohn, Jin Mo Yang, Seungbong Han

BMC Gastroenterol. 2013; 13: 74. Published online 2013 Apr 29. doi: 10.1186/1471-230X-13-74

PMCID:: PMC3644280

Abstract Article PDF–406K

Select item 36839928.

Maximizing Opportunities and Avoiding Mistakes in Triple Therapy for Hepatitis C Virus

A. Sidney Barritt, IV, Michael W. Fried

Gastroenterology. Author manuscript; available in PMC 2013 Jun 17.

Published in final edited form as: Gastroenterology. 2012 May; 142(6): 1314–1323.e1. doi: 10.1053/j.gastro.2012.02.013

PMCID:: PMC3683992

Abstract Article PDF–1.0M

Select item 36912489.

Variation in Both IL28B and KIR2DS3 Genes Influence Pegylated Interferon and Ribavirin Hepatitis C Treatment Outcome in HIV-1 Co-Infection

Ciara Keane, Daire O’Shea, Thomas Reiberger, Markus Peck-Radosavljevic, Gillian Farrell, Colm Bergin, Clair M. Gardiner

PLoS One. 2013; 8(6): e66831. Published online 2013 Jun 24. doi: 10.1371/journal.pone.0066831

PMCID:: PMC3691248

Abstract Article PDF–232K

Select item 370184710.

Advanced fibrosis is not a negative pretreatment predictive factor for genotype 2 or 3 chronic hepatitis C patients

Hyun Seok Lee, Young Oh Kweon, Won Young Tak, Soo Young Park, Eun Jung Kang, Yu Lim Lee, Hae Min Yang, Hyun Woo Park

Clin Mol Hepatol. 2013 Jun; 19(2): 148–155. Published online 2013 Jun 27. doi: 10.3350/cmh.2013.19.2.148

PMCID:: PMC3701847

Abstract Article PDF–725K

Select item 371825511.

Optimum Ribavirin Exposure Overcomes Racial Disparity in Efficacy of Peginterferon and Ribavirin Treatment for Hepatitis C Genotype 1

Runyan Jin, Ling Cai, Ming Tan, John G. McHutchison, Thomas C. Dowling, Charles D. Howell

Am J Gastroenterol. Author manuscript; available in PMC 2013 Jul 22.

Published in final edited form as: Am J Gastroenterol. 2012 Nov; 107(11): 1675–1683. Published online 2012 Oct 23. doi: 10.1038/ajg.2012.306

PMCID:: PMC3718255

Abstract Article PDF–1.0M

Select item 330464712.

Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus

Yu Jin Kim, Jin Woo Lee, Yun Soo Kim, Sook-Hyang Jeong, Young Seok Kim, Hyung Joon Yim, Bo Hyun Kim, Chun Kyon Lee, Choong Kee Park, Sang Hoon Park

Korean J Hepatol. 2011 Sep; 17(3): 199–205. Published online 2011 Sep 30. doi: 10.3350/kjhep.2011.17.3.199

PMCID:: PMC3304647

Abstract Article PDF–337K

Select item 379347413.

Increased Duration of Dual Pegylated Interferon and Ribavirin Therapy for Genotype 1 Hepatitis C Post-liver Transplantation Increases Sustained Virologic Response: A Retrospective Review

Malcolm M. Wells, Lee S. Roth, Paul Marotta, Mark Levstik, Andrew L. Mason, Vincent G. Bain, Natasha Chandok, Bandar M. Aljudaibi

Saudi J Gastroenterol. 2013 Sep-Oct; 19(5): 223–229. doi: 10.4103/1319-3767.118133

PMCID:: PMC3793474

Abstract Article PDF–758K

Select item 385282514.

Treatment of chronic HCV genotype 1 infection with telaprevir: a Bayesian mixed treatment comparison of fixed-length and response-guided treatment regimens in treatment-naïve and –experienced patients

Armin D Goralczyk, Silke Cameron, Ahmad Amanzada

BMC Gastroenterol. 2013; 13: 148. Published online 2013 Oct 14. doi: 10.1186/1471-230X-13-148

PMCID:: PMC3852825

Abstract Article PDF–746K

Select item 391082015.

Efficacy and Safety of Danoprevir-Ritonavir plus Peginterferon Alfa-2a–Ribavirin in Hepatitis C Virus Genotype 1 Prior Null Responders

Edward J. Gane, Régine Rouzier, Alicja Wiercinska-Drapalo, Dominique G. Larrey, Peter N. Morcos, Barbara J. Brennan, Sophie Le Pogam, Isabel Nájera, Rosemary Petric, Jonathan Q. Tran, Rohit Kulkarni, Ying Zhang, Patrick Smith, Ellen S. Yetzer, Nancy S. Shulman

Antimicrob Agents Chemother. 2014 Feb; 58(2): 1136–1145. doi: 10.1128/AAC.01515-13

PMCID:: PMC3910820

Abstract Article PDF–792K

Select item 391576516.

CD49b, a Major Marker of Regulatory T-Cells Type 1, Predicts the Response to Antiviral Therapy of Recurrent Hepatitis C after Liver Transplantation

Stenard Fabien, Morales Olivier, Ghazal Khaldoun, Viallon Vivian, Aoudjehane Lynda, Ouaguia Laurissa, Goormachtigh Gautier, Calmus Yvon, Delhem Nadira, Conti Filomena

Biomed Res Int. 2014; 2014: 290878. Published online 2014 Jan 19. doi: 10.1155/2014/290878

PMCID:: PMC3915765

Abstract Article PDF–676K

Select item 395173317.

Predictors of consent to pharmacogenomics testing in the IDEAL study

Alison B. Jazwinski, Paul J Clark, Alexander J Thompson, Stuart C. Gordon, Eric J Lawitz, Stephanie Noviello, Clifford A Brass, Lisa D Pedicone, Janice K Albrecht, Mark S Sulkowski, Andrew J Muir

Pharmacogenet Genomics. Author manuscript; available in PMC 2014 Nov 1.

Published in final edited form as: Pharmacogenet Genomics. 2013 Nov; 23(11): 619–623. doi: 10.1097/FPC.0000000000000002

PMCID:: PMC3951733

Abstract Article PDF–47K

Select item 395354518.

Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study

Shuhei Nishiguchi, Hirayuki Enomoto, Nobuhiro Aizawa, Hiroki Nishikawa, Yukio Osaki, Yasuhiro Tsuda, Kazuhide Higuchi, Kazuichi Okazaki, Toshihito Seki, Soo Ryang Kim, Yasushi Hongo, Hisato Jyomura, Naoshi Nishida, Masatoshi Kudo

J Gastroenterol. 2014; 49(3): 492–501. Published online 2013 Mar 30. doi: 10.1007/s00535-013-0785-2

PMCID:: PMC3953545

Abstract Article PDF–550K

Select item 398416519.

Peg-Interferon Plus Ribavirin with or without Boceprevir or Telaprevir for HCV Genotype 1: A Meta-Analysis on the Role of Response Predictors

Nicola Coppola, Mariantonietta Pisaturo, Caterina Sagnelli, Evangelista Sagnelli, Italo F. Angelillo

PLoS One. 2014; 9(4): e94542. Published online 2014 Apr 11. doi: 10.1371/journal.pone.0094542

PMCID:: PMC3984165

Abstract Article PDF–722K

Select item 400050420.

Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children

Suzan El Naghi, Tawhida Y Abdel-Ghaffar, Hanaa El-Karaksy, Elham F Abdel-Aty, Mona S El-Raziky, Aleef A Allam, Heba Helmy, Hanaa A El-Araby, Behairy E Behairy, Mohamed A El-Guindi, Hatem El-Sebaie, Aisha Y Abdel-Ghaffar, Nermin A Ehsan, Ahmed M El-Hennawy, Mostafa M Sira

World J Gastroenterol. 2014 Apr 28; 20(16): 4681–4691. Published online 2014 Apr 28. doi: 10.3748/wjg.v20.i16.4681